Following fields are empty!

1
Search
2
Select
3
Submit
225
Journals
Page 1 of 12
Go to Next Page

Request Journal

Please fill in the form to request a new journal to be added. We will review your request and add it to the Journal Guide as soon as possible.

*

ADMET and DMPK

eISSN: 1848-7718
DOAJ Logo
SIGAPS Level C
Publisher: International Association of Physical Chemists
Visit Publisher homepageVisit journal homepage
Chemistry (miscellaneous)Medicine (miscellaneous)Pharmacology (medical)Pharmacology, Toxicology and Pharmaceutics(all)
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Go to Journal

AIDS Research and Therapy

eISSN: 1742-6405
DOAJ Logo
SIGAPS Level D
Publisher: BioMed Central
Visit Publisher homepageVisit journal homepage
Molecular MedicineVirologyInfectious DiseasesPharmacology (medical)

AIDS Research and Therapy is an open access, peer reviewed journal publishing basic science and clinically important research articles to help abate the spread of AIDS. The journal is edited by Kailash C. Gupta with the assistance of an expert Editorial Board, including Deputy Editor Greg T. Spear, and Section Editors Edward A. Berger (Basic Science), Genoveffa Franchini (Vaccines), Magnus Gisslen (Neuro-AIDS), Richard Koup (Therapeutics), and John J. Rossi (Novel treatment strategies).

Read more
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Go to Journal

AIDS Reviews

ISSN: 1139-6121
SIGAPS Level D
Publisher: Permanyer Publication
ImmunologyMedicine(all)Infectious DiseasesPharmacology (medical)
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Acta Pharmacologica Sinica

ISSN: 1671-4083eISSN: 1745-7254
SIGAPS Level A
Publisher: Springer Nature [academic journals on nature.com]
Visit Publisher homepageVisit journal homepage
Chemistry(all)Medicine(all)Pharmacology (medical)Pharmacology
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Go to Journal

Actualités Pharmaceutiques

ISSN: 0515-3700eISSN: 2352-7978
SIGAPS Level E
Publisher: Elsevier Masson
Visit Publisher homepageVisit journal homepage
Pharmacology (medical)Pharmacology

Chaque mois, la revue Actualités pharmaceutiques vous propose de retrouver toutes les informations indispensables pour votre pratique quotidienne grâce à ses rubriques:Actualités Toute l'actualité médicale, pharmaceutique et professionnelle de l'équipe officinale.FormationDes informations rigoureuses et de qualité indispensables pour la formation continue des pharmaciens : mises au point sur des pathologies, dossier de fond de haut niveau pour faire le point sur une classe thérapeutique.PratiqueDes rubriques régulières couvrant l'ensemble des fonctions de la pratique quotidienne officinale (conseil, dispensation, pharmacovigilance, prévention, substitution, vétérinaire) et des domaines thérapeutiques (allopathie, phytothérapie, homéopathie, dermocosmétologie...).GuideUn mémo riche en informations utiles pour la gestion de l'officine : nouveaux produits, législation, marketing, merchandising, livres, agenda, agencement, gestion et informatique.

Read more
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Go to Journal

Advances in Pharmacological and Pharmaceutical Sciences

ISSN: 2633-4682eISSN: 2633-4690
DOAJ Logo
SIGAPS Level D
Publisher: Wiley
Visit Publisher homepageVisit journal homepageView author guidelinesView aims and scope
Molecular MedicinePharmacology (medical)Pharmacology, Toxicology and Pharmaceutics(all)

Advances in Pharmacological Sciences is a peer-reviewed, open access journal that publishes original research articles and review articles in all areas of pharmacological sciences.

Read more
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Go to Journal

Advances in Therapy

ISSN: 0741-238XeISSN: 1865-8652
SIGAPS Level C
Publisher: Springer
Visit Publisher homepageVisit journal homepage
Medicine(all)Pharmacology (medical)

Advances in Therapy is an international peer-reviewed journal dedicated to the rapid publication of studies in clinical medicine, including research on existing drugs and drugs in development across a range of therapeutic areas.The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research papers, drug reviews, and other contributions to drug therapy, diagnosis, instrumentation, and related fields.Please note: Advances in Therapy's open access articles are published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited.  The author assigns the exclusive right to any commercial use of the article to Springer.  For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/2.5

Read more
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

Les auteurs correspondants des Hospices Civils de Lyon ont la possibilité de publier leurs articles de recherches en Open Access dans cette revue. Pour bénéficier de cette prise en charge, déclarez les "Hospices Civils de Lyon" dans votre affiliation principale et utilisez votre adresse mail "@chu-lyon.fr" lors de la soumission de votre article.

L'éditeur précise les consignes suivantes à respecter lors de la soumission via sa plateforme:

  1. Utilisez votre adresse mail "@chu-lyon.fr" lors de la soumission de votre article
  2. Vérifiez que les Hospices Civils de Lyon apparaissent bien dans la zone "Institution"
  3. Liez votre ORCID à votre compte
  4. Si possible, réalisez la soumission depuis un ordinateur relié au réseau des HCL

ATTENTION:

  • Si l'éditeur vous demande de sélectionner la licence applicable, privilégiez la licence CC-BY à toutes autres.
  • L'accord porte uniquement sur les types d'articles suivants: "Article original", "Article de synthèse".
  • Veuillez noter que les types d'articles suivants ne sont pas couverts par cet accord : "Communication brève" et "Formation continue".
  • Cet accord ne concerne pas les revues Nature et BioMed Central (BMC).
  • Les articles publiés en accès ouvert immédiat au titre de l’accord peuvent être déposés dans leur version finale éditeur dans une archive ouverte, par exemple dans HAL-HCL.
  • Dans le cas des articles sous abonnement, il est permis par la Loi République numérique de déposer dans une archive ouverte le manuscrit auteur accepté d’un article et de le diffuser avec un embargo de 6 mois (sciences dures) ou 12 mois (SHS).

Si vous rencontrez des difficultés ou si vous avez des questions, contactez la Documentation Centrale sur sa.documentationcentrale@chu-lyon.fr ou au 04-72-11-29-99 (31-29-99)